Srb Corp Amgen Inc Transaction History

Srb Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $12,418 - $15,136	-55 Reduced 3.51%	1,514 $366,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $35,499 - $45,106	-155 Reduced 8.99%	1,569 $412,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $386,969 - $436,430	1,724 New	1,724 $388,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $1.48 Million - $1.65 Million	-6,357 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $656,187 - $764,680	2,957 Added 86.97%	6,357 $1.58 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $212,701 - $253,289	983 Added 40.67%	3,400 $782,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $69,456 - $77,241	296 Added 13.96%	2,417 $614,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $57,167 - $70,151	-289 Reduced 11.99%	2,121 $501,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $17,859 - $23,686	98 Added 4.24%	2,410 $488,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $18,164 - $23,347	96 Added 4.33%	2,312 $557,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $102,202 - $122,459	-587 Reduced 20.94%	2,216 $428,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $175,868 - $206,157	-1,055 Reduced 27.35%	2,803 $517,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $697,796 - $786,569	3,858 New	3,858 $733,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

Stay updated on Srb Corp with notifications on news.